Concepedia

Hayahito Nomi

HN

Statistics

Publications

31

Citations

1.3K

H-Index

17

Active since

2005

Affiliations

Osaka Medical and Pharmaceutical University(Current)

Municipal Hirakata City Hospital

Osaka University of Pharmaceutical Sciences

Saiseikai Nakatsu Hospital

Fujita Health University

Hayahito Nomi is an author at Osaka Medical and Pharmaceutical University specializing in medicine, oncology, and prostate cancer.

Publications per year

2005–2023

31

Publications

31

Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial

Michiel S. van der Heijden, Matthew D. Galsky, Yohann Loriot et al. · The Lancet Oncology · 2020 · 498 citations · Full text

, , +14

microRNA-145 Mediates the Inhibitory Effect of Adipose Tissue-Derived Stromal Cells on Prostate Cancer

Kiyoshi Takahara, Masaaki Ii, Teruo Inamoto et al. · Stem Cells and Development · 2016 · 133 citations

, , +16

Incidence of urethral stricture after bipolar transurethral resection of the prostate using <scp>TUR</scp> is: results from a randomised trial

Kazumasa Komura, Teruo Inamoto, Tomoaki Takai et al. · British Journal of Urology · 2014 · 71 citations

, , +15

Adipose-derived stromal cells inhibit prostate cancer cell proliferation inducing apoptosis

Kiyoshi Takahara, Masaaki Ii, Teruo Inamoto et al. · Biochemical and Biophysical Research Communications · 2014 · 56 citations

, , +9

A Panel of MicroRNA Signature as a Tool for Predicting Survival of Patients with Urothelial Carcinoma of the Bladder

Teruo Inamoto, Hirofumi Uehara, Yukihiro Akao et al. · Disease Markers · 2018 · 49 citations · Full text

, , +17

1–5 of 31